摘要
Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.
| 貢獻的翻譯標題 | Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferation |
|---|---|
| 原文 | English |
| 專利號 | 7435800 |
| 出版狀態 | Published - 2006 6月 29 |
UN SDG
此研究成果有助於以下永續發展目標
-
SDG 3 良好的健康和福祉
指紋
深入研究「Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferation」主題。共同形成了獨特的指紋。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver